Your browser doesn't support javascript.
loading
Neoadjuvant chemoteraphy in unresectable ovarian cancer with olaparib and weekly carboplatin plus paclitaxel: a phase II, open label multicenter study (NUVOLA trial).
Marchetti, Claudia; Tudisco, Riccardo; Salutari, Vanda; Pietragalla, Antonella; Scambia, Giovanni; Fagotti, Anna.
Afiliação
  • Marchetti C; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Tudisco R; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Salutari V; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Pietragalla A; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Scambia G; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Fagotti A; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy annafagotti70@gmail.com.
Int J Gynecol Cancer ; 31(8): 1175-1178, 2021 08.
Article em En | MEDLINE | ID: mdl-34131041
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Ftalazinas / Piperazinas / Protocolos de Quimioterapia Combinada Antineoplásica / Carboplatina / Paclitaxel Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Ftalazinas / Piperazinas / Protocolos de Quimioterapia Combinada Antineoplásica / Carboplatina / Paclitaxel Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article